|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Net product revenues | |||||
| Net revenues from collaborations | |||||
| Royalty revenue | |||||
| Total revenues | |||||
| Operating costs and expenses: | |||||
| Cost of goods sold | |||||
| Cost of collaborations and royalties | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total operating costs and expenses | |||||
| Income (loss) from operations | |||||
| Other expense: | |||||
| Interest expense | |||||
| Interest income | |||||
| Loss related to convertible debt | |||||
| Other income (expense), net | |||||
| Total other expense, net | |||||
| Income (loss) before income taxes | |||||
| (Provision for) benefit from income taxes | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gains (losses) on marketable securities | |||||
| Foreign currency translation gains (losses) | |||||
| Defined benefit pension plans, net of tax | |||||
| Net other comprehensive loss | |||||
| Comprehensive income (loss) | |||||
| Net income (loss) per common share, basic (in dollars per share) | |||||
| Net income (loss) per common share, diluted (in dollars per share) | |||||
| Weighted average common shares, basic (in shares) | |||||
| Weighted average common shares, diluted (in shares) |
Loading...